SMO and cancer: SMO L412F mutation is associated with Hedgehog pathway misactivation in other cancers,6 and is among the most common Hedgehog pathway mutations in meningiomas.1 However, SMO L412F mutation is also associated with vismodegib resistance,6 and does not drive ciliary Hedgehog signaling in meningioma cells.4